so it's definitely clear this is a battle now. DW vs shorters.
And to be honest if one director can shift price from 85 cents to 1.24, a 50% jump in weeks, then the shorters are in real trouble if the company continues to perform well on growth.
Expecting sales to fall due to covid and lack of access to doctors is completely normal. Ahh we did just go through a pandemic and still living through it. Funny how the market just discounts that and puts it as company failure.
these are great buying opportunities for PNV. If the company as heading south you wouldn't be seeing DW and other directors putting money into this. So it's obviously heading north.
Imho this is a strong buy at this pricing up to 2.50.
Running tally of Director Share Purchases, page-49
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.43 |
Change
-0.090(3.57%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $2.49 | $2.50 | $2.43 | $2.311M | 940.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 17100 | $2.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.45 | 5973 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |